Spending Review: £29bn for NHS. OHE’s Graham Cookson calls for clarity on productivity and investment in prevention for ...

Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to 10 million deaths annually and impose economic costs exceeding $150 billion by 2050.

What’s behind Trump’s drug pricing proposal? This insight explores key policy tools, global scenarios, and long-term ...

OECD countries formally use QALYs in pricing and reimbursement decisions. See how HTA practices differ and where policies ...

In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés ...

New OHE insight on immunisation: despite high returns on investment, global spending lags. We outline why and how countries ...

Analysis of Trump’s ‘Most Favoured Nation’ Executive Order on drug pricing, its global impact, price convergence aims, and ...